Navigation Links
ESMO 2012 Congress: A path for medical oncology innovations
Date:6/13/2012

int, you should know by now that all biological studies on any materials taken from patients in clinical trials for one purpose cannot be used for another purpose without the patient's fully informed consent."
"But that's absurd, all those patients will have died decades ago. Am I to get consent posthumously?"

The ESMO 2012 Congress full program is available at http://www.esmo.org/events/vienna-2012-congress/program.html

Meeting venue and accommodation

The ESMO 2012 Congress will take place at the Austria Center Vienna, which is located 15 minutes from the city center, within walking distance from the underground station (U1 line) and just a 25 minutes' drive from the airport.

ACV - AUSTRIA CENTER VIENNA http://www.acv.at/
Bruno-Kreisky-Platz 1
1220 Vienna

As Vienna is a highly popular tourist destination, we advise you to book your hotel accommodation as soon as possible: http://www.esmo.org/events/vienna-2012-congress/accommodation.html

Media registration

ESMO welcomes media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card.

Media representatives are required to observe and abide by the ESMO 2012 Media Policy http://www.esmo.org/fileadmin/media/pdf/2012/events/vienna/ESMO-media-policy-update-2012-06.pdf .

To register for the event, please fill out the Complimentary Media Registrat
'/>"/>

Contact: Thomas Balasso
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Nanotechnology breakthrough could dramatically improve medical tests
2. MADRID-MIT M+Vision Consortium hosts Biomedical Innovation Conference 2012
3. Nuisance seaweed found to produce compounds with biomedical potential
4. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
5. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
6. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
7. Ultrasensitive biosensor promising for medical diagnostics
8. Medical device, health professionals attend first national conference on value-driven engineering
9. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
10. Research!America says house funding levels for FY13 could undermine medical progress
11. Miniature pressure sensors for medical touch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/6/2015)... , Aug. 6, 2015  Today, U.S. ... visit Crossmatch ™ to learn firsthand how ... protect data. Crossmatch is a world leader in ... and expertise are helping federal agencies and commercial ... security.   "The vast majority of ...
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... cancer,patients have an abnormality in a specific cell ... pathway may be,especially effective for treating the disease, ... D. Anderson Cancer Center.", , A clearer picture ... 3 kinase (PI3K),pathway to breast cancer development, says ...
... got updated to version 5.0. Proteins are classified,by ... known,pathways. Its main use is probably microarray analysis ... output. Best of,all, its available freely . ... freely in the Nucleic acids research Journal . ...
... An estrogen-like chemical,commonly used to synthesize plastic food ... a specific category of prostate cancer cell,potentially affecting ... to a study published in the January 1 ... to be vulnerable to,exposure to the chemical BPA ...
Cached Biology News:PANTHER Protein Classification System Database 5.0 2PANTHER Protein Classification System Database 5.0 3Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells 2
(Date:9/1/2015)... ... September 02, 2015 , ... Spirax Sarco , ... to its eCommerce site Spirax Sarco Anytime. This platform, offering unique online ordering ... place your next order? Log on to Spirax Sarco Anytime and within minutes ...
(Date:9/1/2015)... , Sept. 1, 2015 Prostate ... death in American men. One in seven ... 233,000 new cases are diagnosed annually. That said, ... using a powerful new technique, MRI Fusion Biopsy, ... large cancer lesions, treating only the affected areas ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... recombinant antibodies, announced today that the National Institutes of Health (NIH) has awarded ... will be administered by the NIH’s National Institute of Diabetes and Digestive and ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... the neuro and pain management space join prominent academics and key investors for ... at Harvard Medical School in Boston. , Neuro Advance Boston focuses on ...
Breaking Biology Technology:Spirax Sarco Announces New Features to Anytime Platform 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2
... (Nasdaq: NYER ) reported results for the fiscal year ... 30, 2008 increased $6.6,million or 10.2% to $71.2 million from ... for the fiscal year ended June 30, 2008 was,$403,520 or ... $86,446 or $.02,per share for the previous fiscal year., ...
... MirixaPro(SM) chosen to enable patient care services in Australia through ... ... NCPA 110th Annual Convention --,Mirixa Corporation, the leader in pharmacy-based ... of Australia, announced,today that they have signed a definitive technology ...
... (OTC,Pink Sheets: SNDY) is pleased to announce that the ... on the Pinksheets Electronic OTC Markets from,Limited Information to ... their Issuer Information Statement, which will be accompanied,by an ... status,upgraded by the end of the quarter., A ...
Cached Biology Technology:Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008 2Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008 3Mirixa Announces Agreement With the Pharmacy Guild of Australia 2Mirixa Announces Agreement With the Pharmacy Guild of Australia 3Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information 2
MOUSE ANTI BOVINE WC1:FITC Immunogen: Bovine lymphocytes...
ANTI S. ENTERID LPS...
... This DuoSet ELISA Development kit contains the ... sandwich ELISAs to measure natural and recombinant ... serum. Each kit contains sufficient materials to ... provided that the following conditions are met: ...
... DuoSet ELISA Development kit contains the basic ... ELISAs to measure natural and recombinant rat ... Each kit contains sufficient materials to ... provided that the following conditions are met: ...
Biology Products: